WithdrawnNCT05870384
Official study titleEffects of Group Interpersonal Psychotherapy (IPT-G) Applied to Family Members Who Caregivers of Patients With Schizophrenia on Caregiver Burden, Social Support, Expression of Emotion, Stigma, and Adherence to Treatment
This study was withdrawn before enrollment.
In BoluSchizophreniaBehavioural studyAges 18–65
- Countries
- Türkiye
- Sponsor
- Abant Izzet Baysal University
CompletedNCT03389425
Official study titleApplication of the Simplified Intervention to Modify Physical Activity, Lifestyle, and Eating Behavior From Dr. Cenk Tek and Colleagues of Yale University to a Sample of Obese Patients With Stable Schizophrenia or Schizoaffective Disorder on Antipsychotic Medications in the Pathways to Housing Multidisciplinary Care Setting: A Feasibility Study
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaBehavioural studyAges 18–65
- Countries
- Sponsor
- University of Calgary
CompletedNCT01622166
Official study titleArt Therapy for Symptom Reduction in Acute Schizophrenia - a Randomised Controlled Trial (Kunsttherapie Zur Symptomreduktion Bei Akuter Schizophrenie - Eine Randomisierte Kontrollierte Pilotstudie)
This study has finished and is no longer accepting participants.
In BerlinSchizophreniaBehavioural studyAges 18–64
- Countries
- Germany
- Sponsor
- Charite University, Berlin, Germany
CompletedNCT06236451
Official study titleA Randomized Controlled Trial to Evaluate Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In BhubaneswarSchizophreniaMedication studyAges 18–60
- Countries
- India
- Sponsor
- All India Institute of Medical Sciences, Bhubaneswar
TerminatedNCT06155695
Official study titleTargeting the Auditory Control Network With Auditory Control Enhancement (ACE) in Schizophrenia
This study ended early.
In PittsburghSchizophreniaDevice studyAges 18–40
- Countries
- United States
- Sponsor
- Brian A Coffman, PhD
CompletedNCT03621540
Official study titleAugmentation of Working Memory Training With Transcranial Direct Current Stimulation (tDCS) in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including DüsseldorfSchizophreniaDevice studyAges 18–60
- Countries
- Germany
- Sponsor
- University Hospital Tuebingen
CompletedNCT02570594
This study has finished and is no longer accepting participants.
In StrasbourgSchizophreniaInterventional studyAges 18–55
- Countries
- France
- Sponsor
- University Hospital, Strasbourg, France
UnknownNCT06617104
Official study titleExplore the Differences in Autonomic Nervous System and Meridian Energy Between Patients With Schizophrenia and Healthy Individuals
Current recruitment status is unconfirmed.
In TaipeiSchizophreniaObservational studyAges 18–65
- Countries
- Taiwan
- Sponsor
- National Taiwan University Hospital
CompletedNCT04430309
What is this study about?This study evaluated the effectiveness of exercise for people with schizophrenia.
This study has finished and is no longer accepting participants.
In Kaohsiung CitySchizophreniaBehavioural studyAges 40+
- Countries
- Taiwan
- Sponsor
- Chang Gung Memorial Hospital
CompletedNCT06226779
Official study titleMindful Exercise Baduanjin Versus Brisk Walking for Cognitive Function in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In Kaohsiung CitySchizophreniaBehavioural studyAges 20–65
- Countries
- Taiwan
- Sponsor
- Chang Gung Memorial Hospital
CompletedNCT07190352
This study has finished and is no longer accepting participants.
In BostonSchizophreniaDevice studyAges 18–65
- Countries
- United States
- Sponsor
- Beth Israel Deaconess Medical Center
CompletedNCT03548155
Official study titleBerberine Effects on Clinical Symptoms and Metabolic Disturbance as an Adjunctive Therapy in Patients With Schizophrenia: a Randomized Double-blind Placebo-controlled Study
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 18–62
- Countries
- Sponsor
- Tianjin Anding Hospital